Bausch + Lomb Announces Results from First Phase 3 Trial of NOV03
Thursday, April 15 2021 | 09 h 33 min | Dry Eye, News, Press Release
Bausch + Lomb and Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics, announced statistically significant...
Read More
Bausch Advances Novel Dry Eye Therapeutic to Phase 3
Tuesday, December 29 2020 | 07 h 28 min | Dry Eye, Latest News, News, Vision Science
Quebec based B+L has announced the second of two Phase 3 studies studies evaluating the investigational treatment NOV03 (perfluorohexyloctane) as a...
Read More
CORE Alerts Practitioners to Mask-Associated Dry Eye (MADE)
Wednesday, September 2 2020 | 14 h 35 min | Dry Eye, News, Vision Science
Widespread use of face masks has been determined essential to combat COVID-19’s spread yet is giving rise to a new phenomenon: increased reports...
Read More
Patented IRPL® Technology Now Available in Canada
Friday, May 1 2020 | 15 h 35 min | Dry Eye, News, Press Release
I-MED Pharma announces Health Canada approval for the E>Eye Laser, which is now available to Canadian eye care professionals With...
Read More
New Treatment for Severe Dry Eye
Thursday, July 11 2019 | 06 h 02 min | Dry Eye, Vision Science
A phase I/II clinical trial for a new treatment of severe dry eye disease has shown promising results The treatment is based on a...
Read More
